Loading…
Belite Bio, Inc is projected to rise to $178.74 by 2027, a +20% move from its current price of $149.33. BLTE is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $145.23 | $149.40 | $153.70 | +0.05% |
| Jul 13 | $143.60 | $149.47 | $155.58 | +0.10% |
| Jul 14 | $142.38 | $149.54 | $157.07 | +0.14% |
| Jul 15 | $141.37 | $149.62 | $158.34 | +0.19% |
| Jul 16 | $140.50 | $149.69 | $159.48 | +0.24% |
| Jul 17 | $139.72 | $149.76 | $160.52 | +0.29% |
| Jul 18 | $139.01 | $149.83 | $161.50 | +0.34% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $139.01 | $149.83 | $161.50 | +0.34% |
| Week 2 | $135.21 | $150.33 | $167.15 | +0.67% |
| Week 3 | $132.47 | $150.84 | $171.75 | +1.01% |
| Week 4 | $130.27 | $151.34 | $175.82 | +1.35% |
| Week 5 | $128.41 | $151.85 | $179.56 | +1.69% |
| Week 6 | $126.80 | $152.36 | $183.07 | +2.03% |
| Week 7 | $125.37 | $152.87 | $186.41 | +2.37% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Belite Bio, Inc is a clinical stage biopharmaceutical drug development company focused on research and development of novel therapeutics with unmet medical needs in the United States. The company operates in the Healthcare sector and its activities are centered on advancing therapies for retinal diseases and other health conditions.
Belite Bio, Inc (BLTE) is trading at $154.02 per share with a market cap of $6.17B, and it ranks 1221. These figures position the asset within a large market-cap space, reflecting its established market presence.
A major floor 16.6% below — a decisive break under it would weaken the trend.
The nearest floor, 9.6% below — buyers have tended to step in here.
The nearest ceiling, 5.6% above — a clean break opens room to run.
A major ceiling 21.3% above — clearing it would confirm fresh momentum.
Key BLTE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BLTE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $153.32 | Sell | $151.58 | Sell |
| MA 10 | $151.29 | Sell | $150.84 | Sell |
| MA 20 | $147.88 | Buy | $149.09 | Buy |
| MA 50 | $147.29 | Buy | $149.84 | Sell |
| MA 100 | $158.09 | Sell | $150.51 | Sell |
| MA 200 | $144.12 | Buy | $138.94 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.62 | Neutral |
| Stoch RSI (14) | 36.96 | Neutral |
| CCI (20) | 20.95 | Neutral |
| Williams %R (14) | -54.36 | Info |
| MACD (12,26,9) | 0.58 | Buy |
| ROC (12) | 2.92 | Buy |
| Bollinger %B (20,2) | 0.56 | Neutral |
| Stochastic %K (14) | 45.64 | Neutral |
| TRIX (15) | 0.12 | Buy |
| Awesome (5,34) | 8.02 | Buy |
| Ultimate (7,14,28) | 47.59 | Neutral |
| Momentum (10) | -0.50 | Sell |
| Aroon Osc (25) | 68.00 | Buy |
| Hull MA (9) | 153.89 | Sell |
| ADX (14) | 10.79 | Neutral |
| ATR (14) | 4.05 | Info |
The near-term technical picture is bullish. RSI14 is 60, indicating constructive momentum, and the price is trading above both the SMA50 ($147.99) and the SMA200 ($142.50).
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $134.93 | $149.33 | $204.00 | 0% | Neutral | |
| $141.79 | $178.74 | $238.69 | +20% | Neutral | |
| $145.69 | $189.07 | $262.30 | +27% | Bullish | |
| $161.39 | $214.56 | $306.66 | +44% | Bullish | |
| $163.06 | $221.45 | $324.54 | +48% | Bullish | |
| $195.72 | $271.02 | $405.96 | +81% | Bullish | |
| $244.50 | $344.74 | $526.60 | +131% | Bullish | |
| $247.16 | $354.48 | $551.16 | +137% | Bullish | |
| $271.52 | $395.76 | $625.47 | +165% | Bullish | |
| $290.23 | $429.64 | $689.36 | +188% | Bullish | |
| $441.39 | $701.05 | $1,198.42 | +369% | Bullish | |
| $683.69 | $1,226.50 | $2,298.99 | +721% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $134.93 | $149.33 | $180.32 | +0.00% |
| August 2026 | $132.02 | $156.01 | $189.45 | +4.48% |
| September 2026 | $131.05 | $155.99 | $191.60 | -0.02% |
| October 2026 | $128.04 | $153.35 | $190.19 | -1.69% |
| November 2026 | $130.36 | $156.96 | $196.24 | +2.35% |
| December 2026 | $133.85 | $161.96 | $204.00 | +3.19% |
Click any year to see its month-by-month BLTE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, BLTE could reach as high as $204.00, with a base case around $149.33 and support toward $134.93 — roughly 0% from $149.33. Price action looks broadly range-bound.
Expect BLTE to range from $141.79 to $238.69 through 2027. The $178.74 average target implies a +20% move from current prices. That is up +20% on the projected 2026 average. A consolidation phase looks the most probable path here.
The BLTE price prediction for 2028 points to an average of $189.07 (low $145.69, high $262.30) — a potential gain of +27% on today's $149.33. Momentum favours further upside here.
In 2029, BLTE is projected to trade between $161.39 and $306.66, averaging $214.56 — a potential gain of +44% from today's $149.33. That is up +13% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Belite Bio, Inc's 2030 outlook centres on $221.45, within a $163.06 to $324.54 range. That is up +3% on the projected 2029 average. That marks a +48% change versus current levels. Momentum favours further upside here.
By 2031, BLTE could reach as high as $405.96, with a base case around $271.02 and support toward $195.72 — roughly +81% from $149.33. Buyers look set to stay in control over this stretch.
Expect BLTE to range from $244.50 to $526.60 through 2032. The $344.74 average target implies a +131% move from current prices. That is up +27% on the projected 2031 average. Momentum favours further upside here.
The BLTE price prediction for 2033 points to an average of $354.48 (low $247.16, high $551.16) — a potential gain of +137% on today's $149.33. Buyers look set to stay in control over this stretch.
In 2034, BLTE is projected to trade between $271.52 and $625.47, averaging $395.76 — a potential gain of +165% from today's $149.33. That is up +12% on the projected 2033 average. Momentum favours further upside here.
Belite Bio, Inc's 2035 outlook centres on $429.64, within a $290.23 to $689.36 range. That is up +9% on the projected 2034 average. That marks a +188% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, BLTE could reach as high as $1,198.42, with a base case around $701.05 and support toward $441.39 — roughly +369% from $149.33. Momentum favours further upside here.
Expect BLTE to range from $683.69 to $2,298.99 through 2050. The $1,226.50 average target implies a +721% move from current prices. That is up +75% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in BLTE today (≈ 6.696578 BLTE) could be worth
$8,213.35
+$7,213.35 (+721%) by 2050 · US Dollar
Based on the average projected BLTE price of $1,226.5 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BLTEwould be worth at today's price.
$1,000 invested in BLTE on Jul 10, 2025 (≈ 16.121232 BLTE) would be worth
$2,407.38
+$1,407.38 (+140.7%) today · 2.41× · US Dollar
Based on a BLTE entry price of $62.03 vs. today's $149.33.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $146.63 | $1,018.41 | +1.8% |
| 1 month ago | $136.62 | $1,093.03 | +9.3% |
| 3 months ago | $172.76 | $864.38 | -13.6% |
| 6 months ago | $154.79 | $964.73 | -3.5% |
| 1 year ago | $62.03 | $2,407.38 | +140.7% |
| All time (4.2y) ago | $10.59 | $14,101.04 | +1310.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BLTE forecast.
Our base-case forecast reaches $300.00 around 2032.
Implied market cap at $300.00: $12.03B
The multi-year forecast shows a clear upward trajectory in the average price. In 2026 the average is $154.02 with a min of $134.93 and a max of $212.03 (ROI 0, sentiment NEUTRAL). By 2027 the average rises to $184.21 (min $145.23, max $248.03, ROI 19.6, sentiment NEUTRAL), and by 2028 the average is $194.89 (min $148.98, max $273.09, ROI 26.5, sentiment BULLISH).
The path continues through 2029 with an average of $220.46 (min $164.25, max $318.71, ROI 43.1) and 2030 with an average of $226.91 (min $165.25, max $336.74, ROI 47.3, sentiment BULLISH). Beyond, 2031 shows average $281.27 (min $200.61, max $427.05, ROI 82.6), 2032 $358.39 (min $250.71, max $555.39, ROI 132.7), 2033 $366.31 (min $251.61, max $578.25, ROI 137.8), 2034 $412.40 (min $278.38, max $662.16, ROI 167.8), 2035 $445.73 (min $295.91, max $727.05, ROI 189.4). The long-range outlook strengthens to 2040 with an average of $733.84 (min $451.50, max $1,278.54, ROI 376.5) and culminates in 2050 with an average of $1,269.32 (min $683.94, max $2,433.25, ROI 724.1).
The sentiment remains BULLISH across the extended horizon, with the maximum forecast hitting $2,433.25 by 2050.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $226.91, a min of $165.25, and a max of $336.74, with ROI of 47.3% and a BULLISH sentiment.
Forecasts show a growing average price path, with the 2028 average at $194.89 and the 2050 average at $1,269.32, plus a peak ROI of 724.1%. The 2026 forecast is $154.02 with ROI of 0 and NEUTRAL sentiment, while later years turn BULLISH. These are estimates and not guarantees.
Yes. The 2032 forecast shows a min of $250.71, an average of $358.39, and a max of $555.39, with ROI of 132.7% and a BULLISH sentiment.
The thirty-day range is $126.37 to $187.72.
Near-term sentiment is BULLISH with RSI 60. The price is above the SMA50 of $147.99 and the SMA200 of $142.50, with a support at $134.93 and a resistance at $154.65.
Belite Bio, Inc Community Discussion
0Share your Belite Bio, Inc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.